InvestorsHub Logo
Followers 16
Posts 395
Boards Moderated 0
Alias Born 12/05/2012

Re: None

Saturday, 04/20/2013 11:16:01 AM

Saturday, April 20, 2013 11:16:01 AM

Post# of 130503
As I understand it neurturin is of the GDNF family(per Wiki)....And since much of AMBS's latest tests have proven how MANF is yielding better results that the GDNF treatments... it would seem logical to me to test MANF in the same manner to compare levels of behavioral improvement."

Ceregene results out...not good for neurturin...maybe game changing for MANF.
https://www.michaeljfox.org/foundation/news-detail.php?news-in-context-second-phase-trial-of-cere-120-yields-disappointing-results
"Two other trophic factors in pre-clinical development for PD are CDNF (conserved dopamine neurotrophic factor) and MANF (mesencephalic astrocyte-derived neurotrophic factor). Both have been shown to have interesting effects in a laboratory setting. It's possible that down the road, either of these could prove to be as good, or even better, than GDNF or neurturin, but for now we just don't know. The research is yet to be done. The scientific community currently knows more about CDNF than it does MANF. Ongoing pursuit of both is warranted."